|Dr. Michael N. Oxman
Dr. Michael N. Oxman will deliver the second annual NIAID Stephen E. Straus Memorial Lecture on Infectious Diseases. Oxman’s talk, “Zoster Vaccine: Development, Current Status and Future Prospects,” will be held on Tuesday, Nov. 10, at 2 p.m., in Wilson Hall, Bldg. 1.
Oxman, a close friend and former colleague of Straus, is a professor of medicine and pathology at the University of California, San Diego, and a staff physician in the infectious diseases section at the Veterans Administration Medical Center in San Diego. He chaired the Shingles Prevention Study, a nationwide clinical trial of the shingles vaccine that ran from 1998 to 2004, enrolling 38,546 volunteers ages 60 years and older at 22 sites in the United States. More than 1,500 of these volunteers were vaccinated at the Clinical Center. The study provided the necessary data to support licensure of the vaccine, which is recommended for adults ages 60 and older.
Oxman’s lecture will review the theoretical basis for the shingles vaccine, discuss the study’s results and their public health relevance and outline future prospects for expanded use of the vaccine and for the development of better vaccines against varicella-zoster virus. He will also discuss his collaboration with Straus, who played a major role in the design and execution of the study as a key member of the planning and executive committees and as the original principal investigator at the NIAID study site.
Straus served NIAID for 30 years as a lab chief and senior investigator, continuing in this latter role even after his appointment as the first director of NCCAM. His scientific accomplishments defined him as an international leader on the pathogenesis, treatment and prevention of human herpesvirus diseases.
A native of New York City, Oxman received his bachelor’s degree from Harvard University in 1958 and his medical degree from Harvard Medical School in 1963.